457 related articles for article (PubMed ID: 25881491)
1. The therapeutic potential of regulatory T cells for the treatment of autoimmune disease.
Bluestone JA; Trotta E; Xu D
Expert Opin Ther Targets; 2015; 19(8):1091-103. PubMed ID: 25881491
[TBL] [Abstract][Full Text] [Related]
2. The role of FOXP3
Mohr A; Atif M; Balderas R; Gorochov G; Miyara M
Clin Exp Immunol; 2019 Jul; 197(1):24-35. PubMed ID: 30830965
[TBL] [Abstract][Full Text] [Related]
3. Stabilizing human regulatory T cells for tolerance inducing immunotherapy.
He X; Koenen HJ; Slaats JH; Joosten I
Immunotherapy; 2017 Aug; 9(9):735-751. PubMed ID: 28771099
[TBL] [Abstract][Full Text] [Related]
4. Antigen-Specific Regulatory T Cell Therapy in Autoimmune Diseases and Transplantation.
Selck C; Dominguez-Villar M
Front Immunol; 2021; 12():661875. PubMed ID: 34054826
[TBL] [Abstract][Full Text] [Related]
5. Manipulating regulatory T cells: a promising strategy to treat autoimmunity.
Zhang D; Tu E; Kasagi S; Zanvit P; Chen Q; Chen W
Immunotherapy; 2015; 7(11):1201-11. PubMed ID: 26568117
[TBL] [Abstract][Full Text] [Related]
6. Nonoverlapping roles of PD-1 and FoxP3 in maintaining immune tolerance in a novel autoimmune pancreatitis mouse model.
Zhang B; Chikuma S; Hori S; Fagarasan S; Honjo T
Proc Natl Acad Sci U S A; 2016 Jul; 113(30):8490-5. PubMed ID: 27410049
[TBL] [Abstract][Full Text] [Related]
7. Foxp3, Regulatory T Cell, and Autoimmune Diseases.
Tao JH; Cheng M; Tang JP; Liu Q; Pan F; Li XP
Inflammation; 2017 Feb; 40(1):328-339. PubMed ID: 27882473
[TBL] [Abstract][Full Text] [Related]
8. [Regulatory T lymphocytes CD4(+): current issues].
Siri A; de Boysson H; Boursier G
Med Sci (Paris); 2012; 28(6-7):646-51. PubMed ID: 22805142
[TBL] [Abstract][Full Text] [Related]
9. Human regulatory T cells: role in autoimmune disease and therapeutic opportunities.
Brusko TM; Putnam AL; Bluestone JA
Immunol Rev; 2008 Jun; 223():371-90. PubMed ID: 18613848
[TBL] [Abstract][Full Text] [Related]
10. Regulatory T cell metabolism at the intersection between autoimmune diseases and cancer.
Kurniawan H; Soriano-Baguet L; Brenner D
Eur J Immunol; 2020 Nov; 50(11):1626-1642. PubMed ID: 33067808
[TBL] [Abstract][Full Text] [Related]
11. CD4+ T-regulatory cells: toward therapy for human diseases.
Allan SE; Broady R; Gregori S; Himmel ME; Locke N; Roncarolo MG; Bacchetta R; Levings MK
Immunol Rev; 2008 Jun; 223():391-421. PubMed ID: 18613849
[TBL] [Abstract][Full Text] [Related]
12. Targeting CD4+CD25+FoxP3+ regulatory T-cells for the augmentation of cancer immunotherapy.
Schabowsky RH; Madireddi S; Sharma R; Yolcu ES; Shirwan H
Curr Opin Investig Drugs; 2007 Dec; 8(12):1002-8. PubMed ID: 18058571
[TBL] [Abstract][Full Text] [Related]
13. T
Raffin C; Vo LT; Bluestone JA
Nat Rev Immunol; 2020 Mar; 20(3):158-172. PubMed ID: 31811270
[TBL] [Abstract][Full Text] [Related]
14. FoxP3 in T
Deng G; Song X; Greene MI
Clin Exp Immunol; 2020 Mar; 199(3):255-262. PubMed ID: 31386175
[TBL] [Abstract][Full Text] [Related]
15. Regulatory T cells: the future of autoimmune disease treatment.
Ryba-Stanisławowska M; Sakowska J; Zieliński M; Ławrynowicz U; Trzonkowski P
Expert Rev Clin Immunol; 2019 Jul; 15(7):777-789. PubMed ID: 31104510
[No Abstract] [Full Text] [Related]
16. Therapeutic approaches to allergy and autoimmunity based on FoxP3+ regulatory T-cell activation and expansion.
Miyara M; Wing K; Sakaguchi S
J Allergy Clin Immunol; 2009 Apr; 123(4):749-55; quiz 756-7. PubMed ID: 19348913
[TBL] [Abstract][Full Text] [Related]
17. Induction of dominant tolerance using monoclonal antibodies.
Agua-Doce A; Graça L
Methods Mol Biol; 2007; 380():405-29. PubMed ID: 17876109
[TBL] [Abstract][Full Text] [Related]
18. Treg cell therapy: How cell heterogeneity can make the difference.
Giganti G; Atif M; Mohseni Y; Mastronicola D; Grageda N; Povoleri GA; Miyara M; Scottà C
Eur J Immunol; 2021 Jan; 51(1):39-55. PubMed ID: 33275279
[TBL] [Abstract][Full Text] [Related]
19. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease.
Sakaguchi S; Ono M; Setoguchi R; Yagi H; Hori S; Fehervari Z; Shimizu J; Takahashi T; Nomura T
Immunol Rev; 2006 Aug; 212():8-27. PubMed ID: 16903903
[TBL] [Abstract][Full Text] [Related]
20. Flt3 ligand expands CD4+ FoxP3+ regulatory T cells in human subjects.
Klein O; Ebert LM; Zanker D; Woods K; Tan BS; Fucikova J; Behren A; Davis ID; Maraskovsky E; Chen W; Cebon J
Eur J Immunol; 2013 Feb; 43(2):533-9. PubMed ID: 23124877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
